TrialJournal of the American Heart Association2026
Total Clinical Event Burden With Edoxaban Monotherapy Versus Dual Antithrombotic Therapy in Atrial Fibrillation and Stable Coronary Artery Disease: Insights From the EPIC-CAD Trial.
Sung-Hwan Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.